Randomized Trial of ACT and a Care Management App in Primary Care-based Buprenorphine Treatment

Description

The proposed IMPOWR Research Center at Montefiore-Einstein (IMPOWR-ME) will create a multidisciplinary and synergistic program of research to test multimodal treatments that address both chronic pain and opioid use disorder. IMPOWR-ME will generate critical knowledge about the effectiveness, implementation, and cost effectiveness of providing Acceptance and Commitment Therapy and/or a care management smartphone app for individuals in primary care-based buprenorphine treatment. Patients with lived experience with chronic pain and/or opioid use disorder, patient and policy advocates, payors, and health system partners will be engaged in all stages of the research. IMPOWR-ME is well-positioned to become a long-lasting hub for stakeholder-engaged research with multidisciplinary senior and early stage investigators focused on reducing overdose through better treatments for OUD and CP.

Conditions

Opioid-use Disorder, Chronic Pain

Talk to us

Study Overview

On this page

Study Details

Study overview

The proposed IMPOWR Research Center at Montefiore-Einstein (IMPOWR-ME) will create a multidisciplinary and synergistic program of research to test multimodal treatments that address both chronic pain and opioid use disorder. IMPOWR-ME will generate critical knowledge about the effectiveness, implementation, and cost effectiveness of providing Acceptance and Commitment Therapy and/or a care management smartphone app for individuals in primary care-based buprenorphine treatment. Patients with lived experience with chronic pain and/or opioid use disorder, patient and policy advocates, payors, and health system partners will be engaged in all stages of the research. IMPOWR-ME is well-positioned to become a long-lasting hub for stakeholder-engaged research with multidisciplinary senior and early stage investigators focused on reducing overdose through better treatments for OUD and CP.

Randomized Trial of Acceptance and Commitment Therapy (ACT) and a Care Management App in Primary Care-based Buprenorphine Treatment

Randomized Trial of ACT and a Care Management App in Primary Care-based Buprenorphine Treatment

Condition
Opioid-use Disorder
Intervention / Treatment

-

Contacts and Locations

Bronx

Montefiore Medical Center, Bronx, New York, United States, 10461

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. 18 years old or older;
  • 2. English or Spanish proficiency;
  • 3. receiving BUP treatment for OUD for at least 14 days (thus a stabilized BUP dose); and
  • 4. CP with at least moderate pain severity (score greater than or equal to 4 on Pain, Enjoyment of Life and General Activity scale (PEG). Comorbid psychiatric conditions and use of psychotropic medications will be allowed.
  • 1. Acute exacerbation of psychiatric conditions precluding the ability to participate in the study (e.g., acute mania, active suicidality/homicidality, psychosis);
  • 2. psychotropic medication changes within the past three months prior to enrollment;
  • 3. CP related to malignancy;
  • 4. received ACT or similar therapeutic intervention in the past;
  • 5. initiated psychotherapy within the past three months;
  • 6. neurocognitive conditions that may prevent participants from accessing telehealth services;
  • 7. current use of a smartphone health platform similar to the Valera app;
  • 8. are unable or unwilling to provide signed consent for participation.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Albert Einstein College of Medicine,

Hector Perez, MD, PRINCIPAL_INVESTIGATOR, Albert Einstein College of Medicine Montefiore Medical Center

Tiffany Liu, MD, STUDY_DIRECTOR, Montefiore

Brianna Norton, DO, STUDY_DIRECTOR, Montefiore

Study Record Dates

2027-10